Amanda Mason, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Executive Center Pkwy Ste 106, Fredericksburg, VA 22401 Phone: 540-446-2654 |
Lauren Elizabeth Myers, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Executive Center Pkwy Ste 106, Fredericksburg, VA 22401 Phone: 540-446-2654 |
Eleanor Martino Voice And Speech Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4107 Lafayette Blvd, Suite 3, Fredericksburg, VA 22408 Phone: 540-220-7501 |
Meredith Darden, SPEECH/LANG PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Jackson St, Fredericksburg, VA 22401 Phone: 540-373-3223 |
Donna Ann Bryant, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3412 Massaponax Church Rd, Fredericksburg, VA 22408 Phone: 540-834-4569 |
Tamara B Kauder, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 321 Park Hill Dr, Fredericksburg, VA 22401 Phone: 540-446-2654 Fax: 540-656-2755 |
Andrea Lynn Cedarleaf, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7320 Smith Station Rd, Fredericksburg, VA 22407 Phone: 540-786-5443 |
Kimberly Gregory Osam, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8020 River Stone Dr, Fredericksburg, VA 22407 Phone: 571-217-8124 |
Denise Schrenk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8020 River Stone Dr, Fredericksburg, VA 22407 Phone: 540-834-2500 |
News Archive
ClubCorp, The World Leader in Private Clubs, announced today that it is hosting the third annual ClubCorp Charity Classic in partnership with the Muscular Dystrophy Association (MDA). This event is the world's largest multi-site charity golf and dining event, with participating clubs teeing up across the country from California to New York.
Teva Pharmaceutical Industries Ltd. today announced positive top-line results from the GALA (Glatiramer Acetate Low-Frequency Administration) Phase III clinical trial assessing the efficacy, safety and tolerability of 40 mg/1 ml glatiramer acetate injection (GA) administered subcutaneously three times a week compared to placebo in relapsing-remitting multiple sclerosis (RRMS) patients.
The expansion of insurance coverage under the health reform law is due largely to an expansion of the government-funded Medicaid program, which is causing some doctors to worry about the specifics of implementation, according to the New York Times. "Absorbing that many people into the system will not be easy. The program is administered and partly financed by the states, which are now racing to figure out how to carry out the necessary changes and simplify enrollment even as they struggle to cope with severe budget cuts and staff shortages."
Researchers at The University of Texas MD Anderson Cancer Center have tracked down a cancer-promoting protein's pathway into the cell nucleus and discovered how, once there, it fires up a glucose metabolism pathway on which brain tumors thrive.
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care had examined their added benefit in a dossier assessment completed in April 2015.
› Verified 4 days ago